Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 8Terminated 6Recruiting 5Unknown 3Active not recruiting 2Suspended 1Not yet recruiting 1No longer available 1Available 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1Genitourinary 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Sarcoma 6Osteosarcoma 4Lymphoma 3Neoplasm Metastasis 2Melanoma 2Gliosarcoma 2Glioblastoma 2Gastrointestinal Stromal Tumors 2Dendritic Cell Sarcoma, Interdigitating 2Colorectal Neoplasms 2Carcinoma, Renal Cell 2Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Neuroblastoma 1Leukemia 1Histiocytic Sarcoma 1Glioma 1Eyelid Squamous Cell Carcinoma 1Endometrial Neoplasms 1Drug-Related Side Effects and Adverse Reactions 1Dendritic Cell Sarcoma, Follicular 1Chondrosarcoma 1Cholangiocarcinoma 1Central Nervous System Neoplasms 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Carcinoma, Squamous Cell × Sarcoma × Clear all
NCT04714983 2024-04-09

DNX-2440 for Resectable Colorectal Liver Metastasis

DNAtrix, Inc.

Phase 1 Suspended
30 enrolled
BreastDermatologicGastrointestinalGenitourinarySarcoma

Breast Neoplasms, Carcinoma, Renal Cell, Carcinoma, Squamous Cell, Melanoma, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡